US Patent 7572914 Kinase inhibitors
Patent 7572914 was granted and assigned to Takeda Pharmaceutical Company on August, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+334 characters)
Article
Patent abstract
The invention relates to compounds of the following formula that may be used to inhibits kinases, as well as compositions of matter and kits comprising these compounds. The present invention also relates to methods for inhibiting kinases, as well as treatment methods using compounds according to the present invention.
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07572914 Kinase inhibitors US Patent 7572914 Kinase inhibitors
Infobox
Patent Number
0757291400
Patent Number
757291400
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075729140
Date of Patent
August 11, 2009
0Patent Application Number
110153480
Date Filed
December 17, 2004
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075729140
Date of Patent
August 11, 2009
0Patent Application Number
110153480
Date Filed
December 17, 2004
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07572914 Kinase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07572914
Date of patent
August 11, 2009
Patent application number
11015348
Date Filed
December 17, 2004
Patent primary examiner
Find more entities like US Patent 7572914 Kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
